Nyxoah S.A.
Nyxoah S.A. (NYXH) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · NYXH · as of Jun 9, 2026
Key Statistics
Explore Nyxoah S.A. Data
nyxh stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 5 · Buy rate: 80.0%
The NYXH analyst consensus is Buy, based on ratings from 5 Wall Street analysts over the past 3 months. The average 12-month price target is $6.00, representing +331.65% upside from the current price of $1.39.
Competitors & Peers
nyxh competitorsNYXH
CATX
GNFT
IVVD
KRMD
OABIStock Performance
Full HistoryAbout Nyxoah S.A.
Nyxoah S.A. is a medical technology company dedicated to developing and bringing to market therapies for sleep disordered breathing conditions. Its flagship offering is the Genio system, a CE-Marked, …
what is nyxoah s.a. · nyxh stock overview · nyxoah s.a. company profile · who is nyxoah s.a. ceo · nyxh NASDAQ · nyxoah s.a. headquarters · nyxoah s.a. business segments
About Stock Overview & Key Data
Nyxoah S.A. (NYXH) is a Healthcare company in the Medical - Instruments & Supplies industry, listed on NASDAQ since Apr 28, 2021. As of the latest trading session, NYXH stock price is $1.39, with a market capitalization of $51.9M. The stock has returned -82.06% over the past 12 months and -69.78% year-to-date.
According to 5 Wall Street analysts, the consensus rating for Nyxoah S.A. stock is Buy, with an average 12-month price target of $6.00. In fiscal year 2025, Nyxoah S.A. reported revenue of $10.0M and net income of -$90.1M. For detailed data — including Nyxoah S.A. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Nyxoah S.A. (NYXH) stock price is $1.39. The stock is traded on NASDAQ under the ticker symbol NYXH. The 52-week range is $1.31 – $8.59.